Hemostasis using Novel Synthetic Peptides for Gastrointestinal Bleeding in Malignant Tumors: A Multicenter Prospective Study

未提供0 个研究点目标入组 30 人开始时间: 2023年8月2日最近更新: 2025年5月29日

试验速览

暂无简介。

•(1) Patients with suspected gastrointestinal bleeding due to malignancy
•(2) ECOG performance status (PS) 0-3
•(3) Patients who received a transfusion of red blood cell products within 1 week prior to enrollment or had a hemoglobin level of less than 8.0 g/dl on blood test within 1 week prior to enrollment

•(1) Cases with disorders of coagulation dysfunction
•(2) Cases with uncontrolled infectious disease
•(3) Patients with a history of hypersensitivity to peptide formulations or protein formulations
•(4) Other cases in which the principal investigator or subinvestigator determines that the subject is unsuitable for the study

Rate of successful hemostasis of bleeding from malignant tumors

未报告次要终点

发起方

未提供